ERBB2 and breast carcinoma: Triple-negative breast cancers (TNBCs), which lack the expression of estrogen receptor (ER) and progesterone receptor (PR) and the amplification of the HER2 gene, are a clinically aggressive and molecularly diverse type of breast cancer [1].